LON:IBT - International Biotechnology Trust Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: GBX 260
  • Forecasted Upside: -63.64 %
  • Number of Analysts: 1
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
GBX 715
▼ -21 (-2.85%)

This chart shows the closing price for IBT by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New International Biotechnology Trust Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for IBT and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for IBT

Analyst Price Target is GBX 260
▼ -63.64% Downside Potential
This price target is based on 1 analysts offering 12 month price targets for International Biotechnology Trust in the last 3 months. The average price target is GBX 260, with a high forecast of GBX 260 and a low forecast of GBX 260. The average price target represents a -63.64% upside from the last price of GBX 715.

This chart shows the closing price for IBT for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 1 investment analysts is to buy stock in International Biotechnology Trust.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/16/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/14/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/13/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/13/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/11/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/9/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/8/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/8/2021

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
11/18/2021BarclaysReiterated RatingOverweightGBX 260
(Data available from 12/9/2016 forward)

News Sentiment Rating

1.16 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/13/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/12/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/12/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/11/2021
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/10/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/10/2021
  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/9/2021
  • 6 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/9/2021

Current Sentiment

  • 6 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

  • No positive mentions tracked during this time.
International Biotechnology Trust logo
International Biotechnology Trust plc specializes in investments in development stage and late stage companies. The majority of the fund's assets are generally invested in smaller and mid-capitalization quoted companies, with a minority in larger capitalization quoted companies. It makes long only investments. It prefers to invest in quoted or unquoted biotechnology and life sciences companies focused on drug discovery and development and in related sectors such as microbiology, life sciences, pharmaceutical research and development, gene research and development, medical devices or healthcare services. The fund seeks to invest in companies engaged in development and/or commercialization of a product, device or enabling technology and also invests in the therapeutic sub-sector. The fund also prefers to invest in companies with strong growth potential from the development and/or commercialization of either a biotechnology drug candidate, medical device or other enabling technology for medical research. It may also invest in specialty pharmaceuticals and life science tools. These companies can range from small private companies with strong science and people that need development funding, to large, multi-billion dollar biotechnology and medical device companies which have portfolios of products, many of which are already used in hospitals, clinics and pharmacies around the world. It makes majority of its investments in smaller and mid-capitalization quoted companies and seeks to invest up to thirty percent of the Company's assets in unquoted companies, while allowing an exposure of up to forty percent in unquoted companies (at the time of investment and after allowing for valuation write-ups and further follow-on investments). The fund typically invests in the United States, but seeks the best investments worldwide and so may also invest in Western Europe, Australia, and Asia. It typically invests between $1 million and $4 million in its portfolio companies. It exits its unquoted investments through the sale of these companies to strategic buyers including major pharmaceutical companies or, in some cases, and through a flotation.
Read More

Today's Range

Now: GBX 715
Low: 715
High: 734.75

50 Day Range

MA: GBX 731.29
Low: 698
High: 760

52 Week Range

Now: GBX 715
Low: 669
High: 862

Volume

27,490 shs

Average Volume

83,878 shs

Market Capitalization

£294.36 million

P/E Ratio

4.42

Dividend Yield

4.07%

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of International Biotechnology Trust?

The following Wall Street sell-side analysts have issued stock ratings on International Biotechnology Trust in the last twelve months: Barclays PLC.
View the latest analyst ratings for IBT.

What is the current price target for International Biotechnology Trust?

1 Wall Street analysts have set twelve-month price targets for International Biotechnology Trust in the last year. Their average twelve-month price target is GBX 260, suggesting a possible downside of 64.4%. Barclays PLC has the highest price target set, predicting IBT will reach GBX 260 in the next twelve months. Barclays PLC has the lowest price target set, forecasting a price of GBX 260 for International Biotechnology Trust in the next year.
View the latest price targets for IBT.

What is the current consensus analyst rating for International Biotechnology Trust?

International Biotechnology Trust currently has 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe IBT will outperform the market and that investors should add to their positions of International Biotechnology Trust.
View the latest ratings for IBT.

How do I contact International Biotechnology Trust's investor relations team?

International Biotechnology Trust's physical mailing address is 10 Harewood Avenue, LONDON, NW1 6AA, United Kingdom. The company's listed phone number is 44 20 7421 7070. The official website for International Biotechnology Trust is www.ibtplc.com.